tiprankstipranks
Trending News
More News >
AIxCrypto Holdings (AIXC)
NASDAQ:AIXC

AIxCrypto Holdings (AIXC) Price & Analysis

Compare
717 Followers

AIXC Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

AIXC FAQ

What was AIxCrypto Holdings’s price range in the past 12 months?
AIxCrypto Holdings lowest stock price was $1.61 and its highest was $8.81 in the past 12 months.
    What is AIxCrypto Holdings’s market cap?
    AIxCrypto Holdings’s market cap is $12.59M.
      When is AIxCrypto Holdings’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were AIxCrypto Holdings’s earnings last quarter?
      Currently, no data Available
      Is AIxCrypto Holdings overvalued?
      According to Wall Street analysts AIxCrypto Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does AIxCrypto Holdings pay dividends?
        AIxCrypto Holdings does not currently pay dividends.
        What is AIxCrypto Holdings’s EPS estimate?
        AIxCrypto Holdings’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does AIxCrypto Holdings have?
        AIxCrypto Holdings has 5,160,383 shares outstanding.
          What happened to AIxCrypto Holdings’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of AIxCrypto Holdings?
          Currently, no hedge funds are holding shares in AIXC

          Company Description

          AIxCrypto Holdings

          AIxCrypto Holdings, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was formerly known as Qualigen Therapeutics, Inc. and changed its name to AIxCrypto Holdings, Inc. in November 2025. The company was founded in 1996 and is based in Carlsbad, California.

          Ownership Overview

          0.11%<0.01%99.88%
          Insiders
          0.11%
          Mutual Funds
          <0.01% Other Institutional Investors
          99.88% Public Companies and
          Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks